Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Primary Care Diabetes|March 7, 2026
Current evidence on lipid ratios for cardiovascular risk assessment in diabetes: A reviewE Carretero-Anibarro, D Orozco-BeltranInternational Journal of Clinical Practice|February 27, 2016
Basal insulin initiation in primary vs. specialist care: similar glycaemic control in two different patient populationsD Orozco-Beltran, C Pan, A L Svendsen, et al.The Journal of Clinical Endocrinology and Metabolism|September 9, 2011
Weight beneficial treatments for type 2 diabetesL F Meneghini, D Orozco-Beltran, K Khunti, et al.Primary Care Diabetes|December 31, 2024
Glycemic and weight control in people with type 2 diabetes: A real-world observational study in primary careD Orozco-Beltran, M Mata-Cases, S Artola-Menéndez, et al.Journal of Clinical Pharmacy and Therapeutics|December 17, 2013
Effect of once-daily insulin detemir on oral antidiabetic drug (OAD) use in patients with type 2 diabetesJ Vora, S Caputo, T Damci, et al.Journal of Human Hypertension|April 4, 2014
Suitability of antiplatelet therapy in hypertensive patientsM J Martínez-Orozco, Z Perseguer-Torregrosa, V F Gil-Guillén, et al.Atencion Primaria|October 1, 2011
[Ebrictus study. Functional results, survival, and potential years of life lost after the first stroke]J L Clua-Espuny, J L Piñol-Moreso, A Panisello-Tafalla, et al.International Journal of Clinical Practice|June 14, 2013
Barriers associated with poor control in Spanish diabetic patients. A consensus studyM C Carratalá-Munuera, V F Gil-Guillen, D Orozco-Beltran, et al.Diabetes, Obesity & Metabolism|July 27, 2012
The safety and efficacy of adding once-daily insulin detemir to oral hypoglycaemic agents in patients with type 2 diabetes in a clinical practice setting in 10 countriesK Khunti, S Caputo, T Damci, et al.Pageof 1